Similarly, in the case of THAP9-AS1, its upregulation was linked to a poor prognosis and poor overall survival in ACC, LGG, PRAD, SARC, and THCA (Figure 7c) and poor DFS in ACC, KICH, and MESO, while its downregulated expression was linked to poor DFS in KIRC (Figure 8c). The gene discussed is THAP9; the disease is adrenal cortex carcinoma.